Ascendis Health has confirmed its plan to delist from the JSE in the first week of December, following an overwhelming mandate from its investors. This decision marks the culmination of the company’s significant turnaround strategy. Not long ago, it faced the prospect of bankruptcy. A resounding 93% of the company’s shareholders voted in favour of the move. This provides CEO…